Abstract:Anticancer drugs induce apoptotic and non-apoptotic cell death in various cancer types. The signaling pathways for anticancer drug-induced apoptotic cell death have been shown to differ between drug-sensitive and drug-resistant cells. In atypical multidrug-resistant leukemia cells, the c-Jun/activator protein 1 (AP-1)/p53 signaling pathway leading to apoptotic death is altered. Cancer cells treated with anticancer drugs undergo c-Jun/AP-1–mediated apoptotic death and are involved in c-Jun N-terminal kinase activation and growth arrest- and DNA damage-inducible gene 153 (Gadd153)/CCAAT/enhancer-binding protein homologous protein pathway induction, regardless of the p53 genotype. Gadd153 induction is associated with mitochondrial membrane permeabilization after anticancer drug treatment and involves a coupled endoplasmic reticulum stress response. The induction of apoptosis by anticancer drugs is mediated by the intrinsic pathway (cytochrome c, Cyt c) and subsequent activation of the caspase cascade via proapoptotic genes (e.g., Bax and Bcl-xS) and their interactions. Anticancer drug-induced apoptosis involves caspase-dependent and caspase-independent pathways and occurs via intrinsic and extrinsic pathways. The targeting of antiapoptotic genes such as Bcl-2 enhances anticancer drug efficacy. The modulation of apoptotic signaling by Bcl-xS transduction increases the sensitivity of multidrug resistance-related protein-overexpressing epidermoid carcinoma cells to anticancer drugs. The significance of autophagy in cancer therapy remains to be elucidated. In this review, we summarize current knowledge of cancer cell death-related signaling pathways and their alterations during anticancer drug treatment and discuss potential strategies to enhance treatment efficacy.

Splicing DNA Damage Adaptations for the Management of Cancer Cells

Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling.

Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.

Targeting DNA damage response pathways in cancer

DNA damage and the balance between survival and death in cancer biology

Modulation of apoptosis signaling pathways and cell cycle regulation.

Anti-Apoptotic Mechanisms of Drug Resistance in Cancer

Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair

Molecular Insight into the Apoptotic Mechanism of Cancer Cells: An Explicative Review

Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies

Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics

RNA splicing dysregulation and the hallmarks of cancer

DNA Damage and Its Role in Cancer Therapeutics

Complex Interplay between DNA Damage and Autophagy in Disease and Therapy

Molecular signals in anti-apoptotic survival pathways

Evading apoptosis in cancer

Avoidance of apoptosis as a mechanism of drug resistance

The DNA damage-induced cell death response: a roadmap to kill cancer cells

Mechanism of interaction between autophagy and apoptosis in cancer

Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy

Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML